Publication Date:
1980-04-11
Description:
Arecoline, a cholinergic muscarinic receptor agonist, induced rapid eye movement sleep significantly more rapidly in patients with primary affective illness in remission than in normal control subjects matched for age and sex. These results, and others, suggest that patients with primary affective illness may have a supersensitive cholinergic system both when they are ill and when their symptoms are in clinical remission.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Sitaram, N -- Nurnberger, J I Jr -- Gershon, E S -- Gillin, J C -- New York, N.Y. -- Science. 1980 Apr 11;208(4440):200-2.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/7361118" target="_blank"〉PubMed〈/a〉
Keywords:
Adult
;
Affective Symptoms/drug therapy/*physiopathology
;
Arecoline/*pharmacology
;
Female
;
Humans
;
Injections, Intravenous
;
Male
;
Sleep Wake Disorders/physiopathology
;
Sleep, REM/*drug effects
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink